Page 58 - pdf_publisher2

38. John C. Pickup. Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes. / Diabetes Care.—2004. — 27.— P. 813'823.

39. Juan F. Navarro , Carmen Mora . Role of inflammation in dia' betic complications. / Nephrology Dialysis Transplantation.— 2005.— 20(12).— P. 2601'2604

40. James B. Meigs, Martin K. Rutter, Lisa M. Sullivan., et al. Impact of Insulin Resistance on Risk of Type 2 Diabetes and Cardiovascular Disease in People With Metabolic Syndrome. / Diabetes Care. — 2007.— 30.— P. 1219'1225.

41. James B. Meigs, Peter W. F. Wilson, Caroline S. Fox., et al. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease. / The Journal of Clinical Endocrinology & Metabolism.— 2006.— Vol. 91.— No. 8.— P. 2906'2912.

42. Joshua A. Beckman, Allison B. Goldfine, Andrea Dunaif., et al. Endothelial Function Varies According to Insulin Resistance Disease Type./ Diabetes Care.— 2007. — 30.— P. 1226—1232. 43. Libby P., Aikawa M. Mechanism of plaque stablization with statins. / American journal of cardiology.— 2003.—20.—P. 4A' 8B.

44. Ortego M.,Bustos C. Atorvastatin reduces NF 'kB activation and chemokine expressin in vacular smooth muscle cells and

mononuclear cells / Atherosclerosis.— 1999. — 147.— P. 253' 261.

45. Peter Libby, Paul M. Ridker, Attilio Maseri. Inflammation and Atherosclerosis. / Circulation. — 2002.— 105.— P. 1135 46. Steven E. Kahn, Bernard Zinman, Steven M. Haffner, M. et al. Obesity Is a Major Determinant of the Association of C—Reac' tive Protein Levels and the Metabolic Syndrome in Type 2 Dia' betes. / Diabetes.— 2006.— 55.— P. 2357—2364.

47. Steven E. Shoelson, Jongsoon Lee and Allison B. Goldfine. Inflammation and insulin resistance. / J. Clin. Invest. —2006. — 116.— 1793'1801.

48. Stephanie Brandlein , Nicole Rauschert , Leo Rasche . The human IgMantibody SAM—6 induces tumor—specific apopto' sis with oxidized low—density lipoprotein. // Molecular Cancer Therapeutics.— 2007. — 6. — P. 326'333.

49. Scandinavian Simvastatin Survival Study Group: Randomaised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)./ Lancet.— 1994.— 344.— P. 1383'9.

Уважаемые читатели!

Если Вас заинтересовали проблемы, которые поднимает наш журнал.

Если Вы хотите ближе познакомиться с деятельностью Фонда «Паллиативная медицина и реабилитация больных».

Посетите наш сайт в Интернете, по адресу:

Page 58 - pdf_publisher2_project

Page 58 - pdf_publisher2_project